All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
A new collaboration between Ra Pharmaceuticals Inc. and Merck & Co. Inc. will focus on harnessing the therapeutic power of peptide drugs through a platform technology that offers candidates pre-designed for cell permeability and oral bioavailability.